Novo Nordisk, a leader in the worldwide diabetes and obesity care market, has been witnessing stellar performance of its ...

NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

GIP can also trigger insulin creation and feelings of fullness. Note that semaglutide is available as either an oral tablet or an injection, whereas tirzepatide is available only as an injection.

Novo Nordisk continues to build a case for its oral semaglutide GLP-1 class diabetes drug, with latest results from a phase 3a trial showing it is more effective than placebo at reducing blood ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Rybelsus and Ozempic have many similarities but also have significant differences. They both contain the same active ingredient, semaglutide. Rybelsus is an oral tablet version of semaglutide taken ...